ISLV yields 2000000.00% · JNJ yields 2.14%● Live data
📍 ISLV pulled ahead of the other in Year 1
Combined, ISLV + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ISLV + JNJ for your $10,000?
International Silver, Inc., an exploration stage company, engages in the acquisition and exploration of mineral properties in North and South America. It primarily explores for silver deposits. The company's primary rights and properties include the Butte silver mining project, which includes approximately 380 acres of surface rights and 1,000 acres of mineral rights located in the Butte Mining District of Silver Bow County, Montana; and the Calico silver project, an exploration project, located in the Calico Mining District of San Bernardino County, California. Its primary rights and properties also comprise the Pioche project that comprises a block of 495 acres of unpatented Federal lode mining claims adjacent to the Prince Mine and 450 acres of unpatented Federal lode claims adjacent to the Caselton Mine located in the Pioche Mining District of Lincoln County, Nevada. The company was formerly known as Western States Engineering and Construction, Inc. and changed its name to International Silver, Inc. in June 2006. International Silver, Inc. was incorporated in 1992 and is headquartered in Tucson, Arizona.
Full ISLV Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.